Last reviewed · How we verify
Placebo breath-actuated inhaler — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo breath-actuated inhaler (Placebo breath-actuated inhaler) — Teva Branded Pharmaceutical Products R&D, Inc.. A placebo inhaler device that delivers no active pharmaceutical ingredient, used as a control comparator in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo breath-actuated inhaler TARGET | Placebo breath-actuated inhaler | Teva Branded Pharmaceutical Products R&D, Inc. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo breath-actuated inhaler CI watch — RSS
- Placebo breath-actuated inhaler CI watch — Atom
- Placebo breath-actuated inhaler CI watch — JSON
- Placebo breath-actuated inhaler alone — RSS
Cite this brief
Drug Landscape (2026). Placebo breath-actuated inhaler — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-breath-actuated-inhaler. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab